InsidersTradesSigma
Follow the Amarantus Bioscience Holdings, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €63k. The latest transaction was disclosed on 2 February 2016 (J). Among the most active insiders: COMMISSIONG GERALD. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Amarantus Bioscience Holdings, Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases. It is listed on NASDAQ.